12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers

  • Regencell Bioscience RGC shares rose 30.57% to $30.02 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 144.2K shares, which is 15.15 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $379.6 million.
  • Aprea Therapeutics APRE stock increased by 4.51% to $5.32. Aprea Therapeutics's trading volume hit 102.6K shares by close, accounting for 5.81% of its average volume over the last 100 days. The company's market cap stands at $112.7 million.
  • Simulations Plus SLP stock moved upwards by 3.9% to $40.98. The company's market cap stands at $825.0 million.
  • INVO Bioscience INVO stock rose 3.78% to $3.29. The company's market cap stands at $34.5 million.
  • MannKind MNKD stock increased by 3.34% to $4.63. The company's market cap stands at $1.1 billion.
  • Atreca BCEL shares increased by 2.6% to $5.91. The company's market cap stands at $218.0 million.

Losers

  • Mirum Pharmaceuticals MIRM stock declined by 4.99% to $17.74 during Wednesday's after-market session. The market value of their outstanding shares is at $541.3 million.
  • ATI Physical Therapy ATIP stock decreased by 4.98% to $3.63. The market value of their outstanding shares is at $713.8 million.
  • TransCode Therapeutics RNAZ stock fell 4.77% to $3.0. The market value of their outstanding shares is at $38.7 million.
  • Corvus Pharmaceuticals CRVS stock fell 2.54% to $6.16. The market value of their outstanding shares is at $261.3 million.
  • Protagenic Therapeutics PTIX stock fell 2.16% to $1.82. The market value of their outstanding shares is at $30.5 million.
  • OpGen OPGN shares declined by 2.16% to $2.72. The company's market cap stands at $104.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!